These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9406579)

  • 1. A novel BRCA1 mutation in an identical twin pair with similar clinical histories.
    Miesfeldt S; Turner BL; Lovell MA; Cooper MR; Lescallett J; Jones SM
    Cancer Genet Cytogenet; 1998 Jan; 100(1):43-8. PubMed ID: 9406579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Breast cancer in monozygotic twins].
    Hladíková A; Plevová P; Macháčková E
    Klin Onkol; 2013; 26(3):213-7. PubMed ID: 23763326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copy number variations are not modifiers of phenotypic expression in a pair of identical twins carrying a BRCA1 mutation.
    Lasa A; Ramón y Cajal T; Llort G; Suela J; Cigudosa JC; Cornet M; Alonso C; Barnadas A; Baiget M
    Breast Cancer Res Treat; 2010 Oct; 123(3):901-5. PubMed ID: 20369283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelic imbalance on chromosomes 13 and 17 and mutation analysis of BRCA1 and BRCA2 genes in monozygotic twins concordant for breast cancer.
    Försti A; Luo L; Vorechovsky I; Söderberg M; Lichtenstein P; Hemminki K
    Carcinogenesis; 2001 Jan; 22(1):27-33. PubMed ID: 11159737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in phenotypic expression of a new BRCA1 mutation in identical twins.
    Diez O; Brunet J; Sanz J; del Rio E; Alonso MC; Baiget M
    Lancet; 1997 Sep; 350(9079):713. PubMed ID: 9291910
    [No Abstract]   [Full Text] [Related]  

  • 7. Hereditary breast cancer associated with a germline BRCA2 mutation in identical female twins with similar disease expression.
    Delgado L; Fernández G; González A; Bressac-de Paillerets B; Gualco G; Bombled J; Cataldi S; Sabini G; Roca R; Musé IM
    Cancer Genet Cytogenet; 2002 Feb; 133(1):24-8. PubMed ID: 11890985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.
    Milne RL; Osorio A; Cajal TR; Vega A; Llort G; de la Hoya M; Díez O; Alonso MC; Lazaro C; Blanco I; Sánchez-de-Abajo A; Caldés T; Blanco A; Graña B; Durán M; Velasco E; Chirivella I; Cardeñosa EE; Tejada MI; Beristain E; Miramar MD; Calvo MT; Martínez E; Guillén C; Salazar R; San Román C; Antoniou AC; Urioste M; Benítez J
    Clin Cancer Res; 2008 May; 14(9):2861-9. PubMed ID: 18451254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers.
    Jakubowska A; Gronwald J; Menkiszak J; Górski B; Huzarski T; Byrski T; Edler L; Lubiñski J; Scott RJ; Hamann U
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):270-5. PubMed ID: 17301259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer in twins: genetic and nongenetic familial risk factors.
    Ahlbom A; Lichtenstein P; Malmström H; Feychting M; Hemminki K; Pedersen NL
    J Natl Cancer Inst; 1997 Feb; 89(4):287-93. PubMed ID: 9048832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
    Antoniou AC; Durocher F; Smith P; Simard J; Easton DF;
    Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age.
    van der Kolk DM; de Bock GH; Leegte BK; Schaapveld M; Mourits MJ; de Vries J; van der Hout AH; Oosterwijk JC
    Breast Cancer Res Treat; 2010 Dec; 124(3):643-51. PubMed ID: 20204502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers.
    Milne RL; Osorio A; Ramón y Cajal T; Baiget M; Lasa A; Diaz-Rubio E; de la Hoya M; Caldés T; Teulé A; Lázaro C; Blanco I; Balmaña J; Sánchez-Ollé G; Vega A; Blanco A; Chirivella I; Esteban Cardeñosa E; Durán M; Velasco E; Martínez de Dueñas E; Tejada MI; Miramar MD; Calvo MT; Guillén-Ponce C; Salazar R; San Román C; Urioste M; Benítez J
    Breast Cancer Res Treat; 2010 Jan; 119(1):221-32. PubMed ID: 19370414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations.
    Borg A; Dørum A; Heimdal K; Maehle L; Hovig E; Møller P
    Dis Markers; 1999 Oct; 15(1-3):79-84. PubMed ID: 10595257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.
    Berry DA; Parmigiani G; Sanchez J; Schildkraut J; Winer E
    J Natl Cancer Inst; 1997 Feb; 89(3):227-38. PubMed ID: 9017003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A large kindred with 17q-linked breast and ovarian cancer: genetic, phenotypic, and genealogical analysis.
    Goldgar DE; Fields P; Lewis CM; Tran TD; Cannon-Albright LA; Ward JH; Swensen J; Skolnick MH
    J Natl Cancer Inst; 1994 Feb; 86(3):200-9. PubMed ID: 8283492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriers.
    Hughes DJ; Ginolhac SM; Coupier I; Corbex M; Bressac-de-Paillerets B; Chompret A; Bignon YJ; Uhrhammer N; Lasset C; Giraud S; Hardouin A; Berthet P; Peyrat JP; Fournier J; Nogues C; Lidereau R; Muller D; Fricker JP; Longy M; Toulas C; Guimbaud R; Maugard C; Olschwang S; Yannoukakos D; Durocher F; Moisan AM; Simard J; Mazoyer S; Lynch HT; Szabo C; Lenoir GM; Goldgar DE; Stoppa-Lyonnet D; Sinilnikova OM
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):265-7. PubMed ID: 15668505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancer.
    Heimdal K; Maehle L; Apold J; Pedersen JC; Møller P
    Eur J Cancer; 2003 Oct; 39(15):2205-13. PubMed ID: 14522380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population.
    Simchoni S; Friedman E; Kaufman B; Gershoni-Baruch R; Orr-Urtreger A; Kedar-Barnes I; Shiri-Sverdlov R; Dagan E; Tsabari S; Shohat M; Catane R; King MC; Lahad A; Levy-Lahad E
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3770-4. PubMed ID: 16537453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.